SHARE

mCig Inc (OTCMKTS:MCIG) a provider of technology, services and products for dispensaries, consumers and growers within the worldwide medicinal and recreational marijuana market reported that it finalized a deal to become the Master Distributor of the CannaPod products.

The deal

The company said that this innovative deal was finalized as result of the collaborative efforts of the increasing mCig Sales Team and the Construction segment. As part of the deal, the Sales Team will be obtaining two hundred prepared and pre-qualified bids worth $40 million from the CannaPods current sales pipeline.

Moreover, the Construction Division will serve as the sole “preferred builder” for all clients who would prefer on-site support. The modular cannabis construction industry is growing, and CannaPods, with its advanced technology, associated with the company’s Sales Team and Construction segment, is well-positioned to lead the marketplace.

The expert view

Ron Sassano, the Head of mCig, said that they are constantly striving hard to locate new services and products they can offer to cannabis grower small and large, and they were aware there was a definite requirement for a better solution for cultivators who demand efficient, scalable, durable and tightly regulated growing environments.

The company grabbed the opportunity to associate with CannaPods and realized that their pending patent and dedication to build the best modular construction items in the cannabis market made them the type of affiliate the management wanted to work with the company.

The plans

Mr. Sassano further said that mCig Inc (OTCMKTS:MCIG) is looking forward to allow larger and more experienced sales team work to conclude the deals in the pipeline. The management expects to close at least 10% of total deals which would result in additional revenue to start the initiative. Mr. Sassano termed the existing leads as the ‘tip of the iceberg’ as the company will be introducing CannaPods at national cannabis events.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

https://www.journaltranscript.com/disclaimer

LEAVE A REPLY